The need for balanced dengue vaccine protection: Insights from Thai surveillance data on four serotypes. [PDF]
PLoS Negl Trop DisKhosavanna RR +7 more
europepmc +1 more source
A Dendrimer-Based Multiple Antigenic Peptide (MAP) Approach for Dengue Vaccine Development: In Silico and In Vivo Insights on Safety and Effectiveness. [PDF]
Biology (Basel)Wajeeha AW +6 more
europepmc +1 more source
Efficacy of Multivalent Dengue Vaccine Candidates Predicted In Silico. [PDF]
Vaccines (Basel)Hyeon S +6 more
europepmc +1 more source
Hypersensitivity reactions to dengue vaccine TAK-003 (Qdenga®) following an immunization campaign targeting children and adolescents. [PDF]
Rev Soc Bras Med TropBahia MPS +5 more
europepmc +1 more source
Author Correction: The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine. [PDF]
NPJ VaccinesEscudero I +7 more
europepmc +1 more source
Intention to Receive the TAK-003 Dengue Vaccine and Associated Factors Among Adults in Rural Northern Thailand. [PDF]
Vaccines (Basel)Polpitakchai C +9 more
europepmc +1 more source
The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine. [PDF]
NPJ VaccinesEscudero I +7 more
europepmc +1 more source
Dengue Serostatus and Dengue Vaccine Safety and Efficacy
New England Journal of Medicine, 2018 Posfay-Barbe KM, L’Huillier AG
openaire +5 more sources
The urgent need for a licensed dengue vaccine in the Philippines. [PDF]
Ther Adv Vaccines ImmunotherCordero DA.
europepmc +1 more source
Dengue vaccines: closer but not there yet [PDF]
Memórias do Instituto Oswaldo Cruz, 2011 Galler, Ricardo +2 more
openaire +4 more sources